000 | 01486 a2200433 4500 | ||
---|---|---|---|
005 | 20250514000748.0 | ||
264 | 0 | _c20010614 | |
008 | 200106s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _avan Egmond, M | |
245 | 0 | 0 |
_aEnhancement of polymorphonuclear cell-mediated tumor cell killing on simultaneous engagement of fcgammaRI (CD64) and fcalphaRI (CD89). _h[electronic resource] |
260 |
_bCancer research _cMay 2001 |
||
300 |
_a4055-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigens, CD _xbiosynthesis |
650 | 0 | 4 |
_aBreast Neoplasms _ximmunology |
650 | 0 | 4 |
_aCytotoxicity, Immunologic _ximmunology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMultiple Myeloma _ximmunology |
650 | 0 | 4 |
_aNeutrophils _xdrug effects |
650 | 0 | 4 |
_aReceptors, Fc _xbiosynthesis |
650 | 0 | 4 |
_aReceptors, IgG _xbiosynthesis |
650 | 0 | 4 |
_aSignal Transduction _ximmunology |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
650 | 0 | 4 | _aUp-Regulation |
700 | 1 | _avan Spriel, A B | |
700 | 1 | _aVermeulen, H | |
700 | 1 | _aHuls, G | |
700 | 1 | _avan Garderen, E | |
700 | 1 | _avan de Winkel, J G | |
773 | 0 |
_tCancer research _gvol. 61 _gno. 10 _gp. 4055-60 |
|
999 |
_c11290904 _d11290904 |